Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluAS25 revaccination study in elderly adults previously vaccinated in FluAS25-014
2007-002881-36Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of GSK576389A and Fluarix in influenza (2 arms), sponsored by GSK. Primary endpoint: Solicited local and general reactogenicity. Started Aug 2007; status: completed.
02
Drugs
GSK576389AFluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-002881-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002881-36.